Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Desh Nepal

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
Rheumatology (Oxford, England)|August 18, 2023
Role of IL-6 and IL-6 targeted therapy in systemic lupus erythematosusDesh Nepal, David Gazeley
The New England Journal of Medicine|July 26, 2023
Phase 2 Trial of Peresolimab for Adults with Rheumatoid ArthritisDesh Nepal, Michael Putman
Rheumatic Diseases Clinics of North America|June 18, 2023
Giant Cell Arteritis and Polymyalgia Rheumatica: Treatment Approaches and New TargetsDesh Nepal, Michael Putman, Sebastian Unizony
The Lancet. Rheumatology|January 22, 2024
Unintentional unblinding in rheumatic disease trialsCody Bruggemeyer, Desh Nepal, Michael Putman
ACR Open Rheumatology|July 27, 2022
Comparative Efficacy Randomized Controlled Trials in Rheumatology GuidelinesKatie Henry, Desh Nepal, Erin Valley, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
Rheumatology (Oxford, England)|August 18, 2023
Role of IL-6 and IL-6 targeted therapy in systemic lupus erythematosusDesh Nepal, David Gazeley
The New England Journal of Medicine|July 26, 2023
Phase 2 Trial of Peresolimab for Adults with Rheumatoid ArthritisDesh Nepal, Michael Putman
Rheumatic Diseases Clinics of North America|June 18, 2023
Giant Cell Arteritis and Polymyalgia Rheumatica: Treatment Approaches and New TargetsDesh Nepal, Michael Putman, Sebastian Unizony
The Lancet. Rheumatology|January 22, 2024
Unintentional unblinding in rheumatic disease trialsCody Bruggemeyer, Desh Nepal, Michael Putman
ACR Open Rheumatology|July 27, 2022
Comparative Efficacy Randomized Controlled Trials in Rheumatology GuidelinesKatie Henry, Desh Nepal, Erin Valley, et al.
Pageof 1